Hossein Nahrevanian,
Maryam Shahi,
Masoud Mohajery,
Seyyed Ali Akbar Shamsian,
Seyyed Mohammad Javad Yazdanpanah,
Background: Cutaneous leishmaniasis is an endemic disease in many regions of Iran, including the city of Mashhad. In recent years, some cases have not responded to Glucantime, the usual treatment for this disease. The cellular immune response caused by T-helper type 1 (Th1) cells has an important role in protection against leishmaniasis, and activation of the T-helper type 2 (Th2) response caus...
